Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy Biotech Investing
Diffusion Pharmaceuticals Reports Safety Data for Phase 3 INTACT Study in Glioblastoma Patients Biotech Investing
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 Pharmaceutical Investing
Naturally Splendid Strengthens Marketing Programs in Advance of Edible Markets Cannabis Investing News
Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Pharmaceutical Investing
Life Science Big News Roundup: NanoSphere Announces Re-election of Board; Harvest One Signs Supply Agreement with GenCanna; MediPharm Labs Provides Operational Update and Increases Average Weekly Production to 75 Million Milligrams Life Science Investing
Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon Pharmaceutical Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
